These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31625456)
1. Identification of novel inhibitor of protein tyrosine phosphatases delta: structure-based pharmacophore modeling, virtual screening, flexible docking, molecular dynamics simulation, and post-molecular dynamics analysis. Ma YC; Yang B; Wang X; Zhou L; Li WY; Liu WS; Lu XH; Zheng ZH; Ma Y; Wang RL J Biomol Struct Dyn; 2020 Sep; 38(15):4432-4448. PubMed ID: 31625456 [TBL] [Abstract][Full Text] [Related]
2. Identification of potential leukocyte antigen-related protein (PTP-LAR) inhibitors through 3D QSAR pharmacophore-based virtual screening and molecular dynamics simulation. Du S; Yang B; Wang X; Li WY; Lu XH; Zheng ZH; Ma Y; Wang RL J Biomol Struct Dyn; 2020 Sep; 38(14):4232-4245. PubMed ID: 31588870 [TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors. Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133 [TBL] [Abstract][Full Text] [Related]
4. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches. Jethwa M; Gangopadhyay A; Saha A J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597 [TBL] [Abstract][Full Text] [Related]
5. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease. Iqbal S; Anantha Krishnan D; Gunasekaran K J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053 [TBL] [Abstract][Full Text] [Related]
6. Identification of HDAC6 selective inhibitors: pharmacophore based virtual screening, molecular docking and molecular dynamics simulation. Yan G; Li D; Zhong X; Liu G; Wang X; Lu Y; Qin F; Guo Y; Duan S; Li D J Biomol Struct Dyn; 2021 Apr; 39(6):1928-1939. PubMed ID: 32178584 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor potentially stable conformations from molecular dynamics as a structure-based pharmacophore model for mapping, screening, and identifying ligands-a new paradigm shift in pharmacophore screening. Shanmugarajan D; David C J Biomol Struct Dyn; 2023 Jul; 41(11):4939-4948. PubMed ID: 35543232 [TBL] [Abstract][Full Text] [Related]
8. 3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25B. Ma Y; Li HL; Chen XB; Jin WY; Zhou H; Ma Y; Wang RL Comput Biol Chem; 2018 Apr; 73():1-12. PubMed ID: 29413811 [TBL] [Abstract][Full Text] [Related]
9. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics. Jade DD; Pandey R; Kumar R; Gupta D J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255 [TBL] [Abstract][Full Text] [Related]
10. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation. Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817 [TBL] [Abstract][Full Text] [Related]
11. Ligand based 3D-QSAR model, pharmacophore, molecular docking and ADME to identify potential fibroblast growth factor receptor 1 inhibitors. Huang L; Wu X; Fu X; Wang H; Tang B; Xiao Y; Zhou C; Zhao Z; Wan Y; Chen H; Tang Z; Yao H; Shan Z; Bu T J Biomol Struct Dyn; 2022 Oct; 40(16):7584-7597. PubMed ID: 33734039 [TBL] [Abstract][Full Text] [Related]
12. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models. Zaka M; Abbasi BH; Durdagi S J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845 [TBL] [Abstract][Full Text] [Related]
13. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2. Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738 [TBL] [Abstract][Full Text] [Related]
14. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors. Sharma A; Thelma BK J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362 [TBL] [Abstract][Full Text] [Related]
15. Identification of the potential dual inhibitor of protein tyrosine phosphatase sigma and leukocyte common antigen-related phosphatase by virtual screen, molecular dynamic simulations and post-analysis. Zhou L; Ma YC; Tang X; Li WY; Ma Y; Wang RL J Biomol Struct Dyn; 2021 Jan; 39(1):45-62. PubMed ID: 31842717 [TBL] [Abstract][Full Text] [Related]
16. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing. Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574 [TBL] [Abstract][Full Text] [Related]
17. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7. Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449 [TBL] [Abstract][Full Text] [Related]
18. 3D QSAR pharmacophore-based virtual screening for the identification of potential inhibitors of tyrosinase. Ghayas S; Ali Masood M; Parveen R; Aquib M; Farooq MA; Banerjee P; Sambhare S; Bavi R J Biomol Struct Dyn; 2020 Jul; 38(10):2916-2927. PubMed ID: 31334690 [TBL] [Abstract][Full Text] [Related]
19. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Jana S; Singh SK J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408 [TBL] [Abstract][Full Text] [Related]